(S)-nicotine increases response to substance ISO RGD:737183 6480464 ZFP36 protein results in increased susceptibility to Nicotine CTD PMID:22093924 , PMID:24095726 (S)-nicotine increases activity EXP 6480464 Nicotine results in increased activity of ZFP36 promoter CTD PMID:21606497 (S)-nicotine multiple interactions EXP 6480464 [Nicotine co-treated with Lipopolysaccharides] results in increased expression of ZFP36 mRNA more ... CTD PMID:21606497 (S)-nicotine multiple interactions ISO RGD:737183 6480464 [Lipopolysaccharides co-treated with Nicotine] results in increased expression of ZFP36 mRNA more ... CTD PMID:22093924 , PMID:24095726 (S)-nicotine increases expression ISO RGD:737183 6480464 Nicotine results in increased expression of ZFP36 mRNA, Nicotine results in increased expression of ZFP36 protein CTD PMID:22093924 , PMID:24095726 1,2,4-trimethylbenzene increases expression ISO RGD:620722 6480464 pseudocumene results in increased expression of ZFP36 protein CTD PMID:17337753 1,2-dimethylhydrazine multiple interactions ISO RGD:620722 6480464 [APC protein affects the susceptibility to 1, 2-Dimethylhydrazine] which results in increased expression of ZFP36 mRNA CTD PMID:27840820 1,2-dimethylhydrazine decreases expression ISO RGD:737183 6480464 1, 2-Dimethylhydrazine results in decreased expression of ZFP36 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:737183 6480464 Ethinyl Estradiol affects the expression of ZFP36 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:620722 6480464 Ethinyl Estradiol results in increased expression of ZFP36 mRNA CTD PMID:17351261 17alpha-ethynylestradiol multiple interactions ISO RGD:737183 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZFP36 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:737183 6480464 Ethinyl Estradiol results in increased expression of ZFP36 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:737183 6480464 Estradiol results in increased expression of ZFP36 mRNA CTD PMID:25210133 17beta-estradiol multiple interactions EXP 6480464 Estradiol promotes the reaction [ESR2 protein affects the expression of ZFP36 mRNA] CTD PMID:20404318 17beta-estradiol affects expression ISO RGD:737183 6480464 Estradiol affects the expression of ZFP36 mRNA CTD PMID:15598610 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ZFP36 mRNA CTD PMID:19153601 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of ZFP36 mRNA CTD PMID:14699072 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:31173147 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:737183 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737183 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ZFP36 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ZFP36 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737183 6480464 Tetrachlorodibenzodioxin results in increased expression of ZFP36 mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737183 6480464 Tetrachlorodibenzodioxin affects the expression of ZFP36 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:620722 6480464 Tetrachlorodibenzodioxin results in decreased expression of ZFP36 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:620722 6480464 Tetrachlorodibenzodioxin affects the expression of ZFP36 mRNA CTD PMID:22298810 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZFP36 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione decreases expression ISO RGD:620722 6480464 1, 2-dithiol-3-thione results in decreased expression of ZFP36 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol increases expression ISO RGD:737183 6480464 bis4-hydroxyphenylsulfone results in increased expression of ZFP36 mRNA CTD PMID:30951980 4-hydroxynon-2-enal decreases expression ISO RGD:737183 6480464 4-hydroxy-2-nonenal results in decreased expression of ZFP36 mRNA CTD PMID:19191707 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of ZFP36 mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide increases expression ISO RGD:737183 6480464 Fenretinide results in increased expression of ZFP36 mRNA CTD PMID:28973697 afimoxifene increases expression EXP 6480464 afimoxifene results in increased expression of ZFP36 mRNA CTD PMID:19153601 afimoxifene multiple interactions EXP 6480464 GPER1 protein affects the reaction [afimoxifene results in increased expression of ZFP36 mRNA] CTD PMID:19153601 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of ZFP36 mRNA CTD PMID:19774075 ammonium chloride affects expression ISO RGD:620722 6480464 Ammonium Chloride affects the expression of ZFP36 mRNA CTD PMID:16483693 antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of ZFP36 mRNA CTD PMID:24449571 arachidonic acid increases expression ISO RGD:737183 6480464 Arachidonic Acid results in increased expression of ZFP36 mRNA CTD PMID:8764118 arsenite(3-) increases phosphorylation ISO RGD:737183 6480464 arsenite results in increased phosphorylation of ZFP36 protein CTD PMID:15014438 arsenite(3-) multiple interactions ISO RGD:737183 6480464 [arsenite results in increased phosphorylation of ZFP36 protein] promotes the reaction [ZFP36 protein binds to YWHAQ protein] CTD PMID:15014438 arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of ZFP36 mRNA CTD PMID:20458559 arsenous acid affects expression EXP 6480464 Arsenic Trioxide affects the expression of ZFP36 mRNA CTD PMID:12749819 belinostat decreases expression EXP 6480464 belinostat results in decreased expression of ZFP36 mRNA CTD PMID:27188386 benzene increases expression ISO RGD:620722 6480464 Benzene results in increased expression of ZFP36 protein CTD PMID:15468289 benzene decreases expression EXP 6480464 Benzene results in decreased expression of ZFP36 mRNA CTD PMID:19162166 benzo[a]pyrene multiple interactions ISO RGD:737183 6480464 AHR protein promotes the reaction [Benzoapyrene results in increased expression of ZFP36 mRNA] CTD PMID:15034205 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of ZFP36 mRNA CTD PMID:22316170 , PMID:26238291 benzo[a]pyrene increases expression ISO RGD:737183 6480464 Benzoapyrene results in increased expression of ZFP36 mRNA CTD PMID:15034205 more ... bisphenol A increases expression ISO RGD:620722 6480464 bisphenol A results in increased expression of ZFP36 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:737183 6480464 bisphenol A results in increased expression of ZFP36 mRNA CTD PMID:30951980 bisphenol A decreases expression ISO RGD:737183 6480464 bisphenol A results in decreased expression of ZFP36 mRNA CTD PMID:25594700 bisphenol F multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZFP36 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:737183 6480464 bisphenol F results in increased expression of ZFP36 mRNA CTD PMID:30951980 buta-1,3-diene decreases expression ISO RGD:737183 6480464 1, 3-butadiene results in decreased expression of ZFP36 mRNA CTD PMID:29038090 butanal decreases expression EXP 6480464 butyraldehyde results in decreased expression of ZFP36 mRNA CTD PMID:26079696 C60 fullerene decreases expression ISO RGD:620722 6480464 fullerene C60 results in decreased expression of ZFP36 mRNA CTD PMID:19167457 C60 fullerene increases expression ISO RGD:620722 6480464 fullerene C60 results in increased expression of ZFP36 mRNA CTD PMID:19167457 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of ZFP36 mRNA CTD PMID:16439709 cadmium dichloride decreases methylation ISO RGD:620722 6480464 Cadmium Chloride results in decreased methylation of ZFP36 promoter CTD PMID:22457795 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ZFP36 mRNA CTD PMID:26260164 cadmium dichloride increases expression ISO RGD:620722 6480464 Cadmium Chloride results in increased expression of ZFP36 mRNA CTD PMID:19010381 Calcimycin multiple interactions ISO RGD:737183 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of ZFP36 mRNA] CTD PMID:25451590 Calcimycin increases expression ISO RGD:737183 6480464 Calcimycin results in increased expression of ZFP36 mRNA CTD PMID:25451590 calcitriol multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ZFP36 mRNA CTD PMID:21592394 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of ZFP36 mRNA CTD PMID:16002434 , PMID:21592394 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of ZFP36 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:737183 6480464 Nanotubes, Carbon analog results in increased expression of ZFP36 mRNA CTD PMID:25554681 carbonyl sulfide increases expression ISO RGD:620722 6480464 carbonyl sulfide results in increased expression of ZFP36 mRNA CTD PMID:19395590 chlorohydrocarbon increases expression ISO RGD:620722 6480464 Hydrocarbons, Chlorinated results in increased expression of ZFP36 mRNA CTD PMID:18077114 chloropicrin increases expression EXP 6480464 chloropicrin results in increased expression of ZFP36 mRNA CTD PMID:26352163 cisplatin increases expression ISO RGD:737183 6480464 Cisplatin results in increased expression of ZFP36 mRNA CTD PMID:21151649 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ZFP36 mRNA CTD PMID:26260164 copper atom multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of ZFP36 mRNA, [NSC 689534 binds to Copper] which results in increased expression of ZFP36 mRNA CTD PMID:20971185 , PMID:24690739 copper(0) multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of ZFP36 mRNA, [NSC 689534 binds to Copper] which results in increased expression of ZFP36 mRNA CTD PMID:20971185 , PMID:24690739 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of ZFP36 mRNA CTD PMID:19549813 corticosterone increases expression ISO RGD:620722 6480464 Corticosterone results in increased expression of ZFP36 mRNA CTD PMID:15755911 cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of ZFP36 mRNA CTD PMID:21980503 crocidolite asbestos increases expression EXP 6480464 Asbestos, Crocidolite results in increased expression of ZFP36 mRNA CTD PMID:18687144 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of ZFP36 mRNA CTD PMID:25562108 cylindrospermopsin increases expression EXP 6480464 cylindrospermopsin results in increased expression of ZFP36 mRNA CTD PMID:24921660 decabromodiphenyl ether affects expression EXP 6480464 decabromobiphenyl ether affects the expression of ZFP36 mRNA CTD PMID:24834073 dexamethasone multiple interactions ISO RGD:737183 6480464 Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of ZFP36 mRNA], Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of ZFP36 protein] CTD PMID:15710351 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZFP36 mRNA CTD PMID:28628672 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of ZFP36 mRNA CTD PMID:25047013 dexamethasone increases expression ISO RGD:737183 6480464 Dexamethasone results in increased expression of ZFP36 mRNA CTD PMID:22733784 , PMID:23946490 dexamethasone multiple interactions ISO RGD:620722 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of ZFP36 mRNA] CTD PMID:20032058 dexamethasone increases expression ISO RGD:620722 6480464 Dexamethasone results in increased expression of ZFP36 mRNA CTD PMID:20032058 diarsenic trioxide affects expression EXP 6480464 Arsenic Trioxide affects the expression of ZFP36 mRNA CTD PMID:12749819 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of ZFP36 mRNA CTD PMID:20458559 dibutyl phthalate increases expression ISO RGD:737183 6480464 Dibutyl Phthalate results in increased expression of ZFP36 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:620722 6480464 Dibutyl Phthalate results in increased expression of ZFP36 mRNA CTD PMID:21266533 , PMID:21745491 dicrotophos increases expression EXP 6480464 dicrotophos results in increased expression of ZFP36 mRNA CTD PMID:28302478 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of ZFP36 mRNA CTD PMID:31068361 diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of ZFP36 protein CTD PMID:21969073 dimethyl sulfoxide affects expression EXP 6480464 Dimethyl Sulfoxide affects the expression of ZFP36 mRNA CTD PMID:24834073 disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of ZFP36 mRNA CTD PMID:18175754 disulfiram multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of ZFP36 mRNA CTD PMID:24690739 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ZFP36 mRNA CTD PMID:29803840 ferric oxide increases expression ISO RGD:737183 6480464 ferric oxide analog results in increased expression of ZFP36 mRNA CTD PMID:24525745 fluoranthene multiple interactions ISO RGD:737183 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of ZFP36 mRNA CTD PMID:28329830 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of ZFP36 mRNA CTD PMID:28937961 furan decreases expression ISO RGD:620722 6480464 furan results in decreased expression of ZFP36 mRNA CTD PMID:26194646 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ZFP36 mRNA CTD PMID:26260164 gentamycin increases expression ISO RGD:620722 6480464 Gentamicins results in increased expression of ZFP36 mRNA CTD PMID:22061828 hemin increases expression ISO RGD:737183 6480464 Hemin results in increased expression of ZFP36 mRNA CTD PMID:24095726 hemin multiple interactions ISO RGD:737183 6480464 zinc protoporphyrin inhibits the reaction [Hemin results in increased expression of ZFP36 mRNA] CTD PMID:24095726 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of ZFP36 mRNA CTD PMID:20044591 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of ZFP36 CTD PMID:18687144 hydrogen sulfide increases expression ISO RGD:737183 6480464 Hydrogen Sulfide results in increased expression of ZFP36 mRNA CTD PMID:31843631 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZFP36 mRNA CTD PMID:28628672 isoeugenol increases expression EXP 6480464 isoeugenol results in increased expression of ZFP36 protein CTD PMID:21969073 isoeugenol multiple interactions EXP 6480464 KT 5720 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein], SB 203580 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein] CTD PMID:21969073 ketamine increases expression ISO RGD:620722 6480464 Ketamine results in increased expression of ZFP36 mRNA CTD PMID:20080153 KT 5720 multiple interactions EXP 6480464 KT 5720 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein] CTD PMID:21969073 lead diacetate increases expression ISO RGD:737183 6480464 lead acetate results in increased expression of ZFP36 mRNA CTD PMID:20542052 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of ZFP36 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions EXP 6480464 [Nicotine co-treated with Lipopolysaccharides] results in increased expression of ZFP36 mRNA more ... CTD PMID:21606497 lipopolysaccharide increases expression ISO RGD:737183 6480464 Lipopolysaccharides results in increased expression of ZFP36 mRNA, Lipopolysaccharides results in increased expression of ZFP36 protein CTD PMID:10975854 more ... lipopolysaccharide multiple interactions ISO RGD:737183 6480464 [Lipopolysaccharides co-treated with Nicotine] results in increased expression of ZFP36 mRNA more ... CTD PMID:15014438 more ... medroxyprogesterone acetate increases expression EXP 6480464 Medroxyprogesterone Acetate results in increased expression of ZFP36 mRNA CTD PMID:15866426 mercury dibromide increases expression EXP 6480464 mercuric bromide results in increased expression of ZFP36 mRNA CTD PMID:26272509 mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ZFP36 mRNA CTD PMID:27188386 mercury dichloride increases expression ISO RGD:620722 6480464 Mercuric Chloride results in increased expression of ZFP36 mRNA CTD PMID:16507785 metformin decreases expression ISO RGD:620722 6480464 Metformin results in decreased expression of ZFP36 mRNA CTD PMID:31324951 methamphetamine increases expression ISO RGD:737183 6480464 Methamphetamine results in increased expression of ZFP36 mRNA CTD PMID:26307267 methamphetamine multiple interactions ISO RGD:620722 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of ZFP36 mRNA CTD PMID:19564919 methamphetamine increases expression ISO RGD:620722 6480464 Methamphetamine results in increased expression of ZFP36 mRNA CTD PMID:19564919 methyllycaconitine multiple interactions EXP 6480464 methyllycaconitine inhibits the reaction [[Nicotine co-treated with Lipopolysaccharides] results in increased expression of ZFP36 mRNA] CTD PMID:21606497 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of ZFP36 mRNA CTD PMID:28001369 mifepristone multiple interactions ISO RGD:737183 6480464 Mifepristone inhibits the reaction [RU24858 inhibits the reaction [Lipopolysaccharides results in increased expression of ZFP36 mRNA]] CTD PMID:15710351 mono(2-ethylhexyl) phthalate increases expression ISO RGD:620722 6480464 mono-2-ethylhexylphthalate results in increased expression of ZFP36 mRNA CTD PMID:16809437 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression EXP 6480464 N more ... CTD PMID:12756304 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ZFP36 mRNA CTD PMID:24810058 naphthalenes increases expression ISO RGD:620722 6480464 Naphthalenes results in increased expression of ZFP36 protein CTD PMID:17337753 nickel atom increases expression ISO RGD:737183 6480464 Nickel results in increased expression of ZFP36 mRNA CTD PMID:12540486 nickel atom increases expression EXP 6480464 Nickel results in increased expression of ZFP36 mRNA CTD PMID:24768652 , PMID:25583101 Niclosamide increases expression EXP 6480464 Niclosamide results in increased expression of ZFP36 mRNA CTD PMID:28284560 nicotine multiple interactions ISO RGD:737183 6480464 [Lipopolysaccharides co-treated with Nicotine] results in increased expression of ZFP36 mRNA more ... CTD PMID:22093924 , PMID:24095726 nicotine increases response to substance ISO RGD:737183 6480464 ZFP36 protein results in increased susceptibility to Nicotine CTD PMID:22093924 , PMID:24095726 nicotine increases activity EXP 6480464 Nicotine results in increased activity of ZFP36 promoter CTD PMID:21606497 nicotine multiple interactions EXP 6480464 [Nicotine co-treated with Lipopolysaccharides] results in increased expression of ZFP36 mRNA more ... CTD PMID:21606497 nicotine increases expression ISO RGD:737183 6480464 Nicotine results in increased expression of ZFP36 mRNA, Nicotine results in increased expression of ZFP36 protein CTD PMID:22093924 , PMID:24095726 orphenadrine affects expression ISO RGD:620722 6480464 Orphenadrine affects the expression of ZFP36 mRNA CTD PMID:23665939 oxaliplatin multiple interactions ISO RGD:620722 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ZFP36 mRNA CTD PMID:25729387 p-chloromercuribenzoic acid multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ZFP36 mRNA CTD PMID:27188386 paracetamol increases expression ISO RGD:737183 6480464 Acetaminophen results in increased expression of ZFP36 mRNA CTD PMID:11752693 paracetamol affects expression ISO RGD:737183 6480464 Acetaminophen affects the expression of ZFP36 mRNA CTD PMID:15606129 , PMID:17562736 paraoxon increases expression ISO RGD:737183 6480464 Paraoxon results in increased expression of ZFP36 mRNA CTD PMID:22093924 paraquat increases expression ISO RGD:737183 6480464 Paraquat results in increased expression of ZFP36 mRNA CTD PMID:12595580 phenformin decreases expression ISO RGD:620722 6480464 Phenformin results in decreased expression of ZFP36 mRNA CTD PMID:31324951 phenobarbital decreases expression ISO RGD:737183 6480464 Phenobarbital results in decreased expression of ZFP36 mRNA CTD PMID:19270015 phenobarbital affects expression ISO RGD:737183 6480464 Phenobarbital affects the expression of ZFP36 mRNA CTD PMID:23091169 phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of ZFP36 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of ZFP36 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate increases expression ISO RGD:737183 6480464 Tetradecanoylphorbol Acetate results in increased expression of ZFP36 mRNA CTD PMID:19945525 phorbol 13-acetate 12-myristate increases expression EXP 6480464 Tetradecanoylphorbol Acetate results in increased expression of ZFP36 mRNA CTD PMID:31068361 pioglitazone multiple interactions EXP 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA CTD PMID:20847119 pirinixic acid increases expression ISO RGD:737183 6480464 pirinixic acid results in increased expression of ZFP36 mRNA CTD PMID:18445702 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:737183 6480464 Pregnenolone Carbonitrile results in increased expression of ZFP36 mRNA CTD PMID:28903501 progesterone increases expression EXP 6480464 Progesterone results in increased expression of ZFP36 mRNA CTD PMID:21795739 propanal decreases expression EXP 6480464 propionaldehyde results in decreased expression of ZFP36 mRNA CTD PMID:26079696 quercetin increases expression EXP 6480464 Quercetin results in increased expression of ZFP36 mRNA CTD PMID:21632981 raloxifene multiple interactions EXP 6480464 ESR1 protein affects the reaction [Raloxifene Hydrochloride results in increased expression of ZFP36 mRNA] CTD PMID:14699072 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of ZFP36 mRNA CTD PMID:14699072 resveratrol increases expression EXP 6480464 Resveratrol results in increased expression of ZFP36 mRNA, Resveratrol results in increased expression of ZFP36 protein CTD PMID:26537190 resveratrol multiple interactions ISO RGD:737183 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of ZFP36 mRNA] CTD PMID:31298478 rotenone increases expression ISO RGD:620722 6480464 Rotenone results in increased expression of ZFP36 mRNA CTD PMID:28374803 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ZFP36 mRNA CTD PMID:29955902 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein] CTD PMID:21969073 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 SCH 23390 multiple interactions ISO RGD:620722 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of ZFP36 mRNA CTD PMID:19564919 Shikonin multiple interactions ISO RGD:737183 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of ZFP36 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of ZFP36 mRNA] CTD PMID:25451590 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of ZFP36 mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of ZFP36 mRNA, Silicon Dioxide analog results in increased expression of ZFP36 protein CTD PMID:23806026 silicon dioxide increases expression ISO RGD:737183 6480464 Silicon Dioxide results in increased expression of ZFP36 mRNA CTD PMID:19073995 silver atom increases expression ISO RGD:737183 6480464 Silver results in increased expression of ZFP36 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:737183 6480464 Silver results in increased expression of ZFP36 mRNA CTD PMID:27131904 sodium arsenite affects localization EXP 6480464 sodium arsenite affects the localization of ZFP36 protein CTD PMID:15944294 sodium arsenite affects localization ISO RGD:737183 6480464 sodium arsenite affects the localization of ZFP36 protein CTD PMID:15944294 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ZFP36 mRNA CTD PMID:12016162 sodium dichromate increases expression ISO RGD:737183 6480464 sodium bichromate results in increased expression of ZFP36 mRNA CTD PMID:27859739 Soman increases expression ISO RGD:620722 6480464 Soman results in increased expression of ZFP36 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:737183 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP36 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP36 mRNA CTD PMID:21641980 , PMID:26378955 tamoxifen affects expression ISO RGD:737183 6480464 Tamoxifen affects the expression of ZFP36 mRNA CTD PMID:17555576 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of ZFP36 mRNA CTD PMID:14699072 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of ZFP36 mRNA CTD PMID:20847119 tert-butyl hydroperoxide multiple interactions EXP 6480464 [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA more ... CTD PMID:20847119 testosterone multiple interactions EXP 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of ZFP36 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:620722 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of ZFP36 mRNA] CTD PMID:20032058 testosterone increases expression EXP 6480464 Testosterone results in increased expression of ZFP36 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:620722 6480464 Carbon Tetrachloride affects the expression of ZFP36 mRNA CTD PMID:12734012 tetrachloromethane increases expression ISO RGD:737183 6480464 Carbon Tetrachloride results in increased expression of ZFP36 mRNA CTD PMID:31919559 thapsigargin increases expression ISO RGD:737183 6480464 Thapsigargin results in increased expression of ZFP36 mRNA CTD PMID:8764118 titanium dioxide multiple interactions ISO RGD:737183 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of ZFP36 mRNA] CTD PMID:31298478 titanium dioxide increases expression ISO RGD:737183 6480464 titanium dioxide analog results in increased expression of ZFP36 mRNA, titanium dioxide results in increased expression of ZFP36 mRNA CTD PMID:23557971 more ... tobramycin increases expression EXP 6480464 Tobramycin results in increased expression of ZFP36 mRNA CTD PMID:26260164 topotecan multiple interactions ISO RGD:620722 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ZFP36 mRNA CTD PMID:25729387 toxaphene decreases expression ISO RGD:620722 6480464 Toxaphene results in decreased expression of ZFP36 mRNA CTD PMID:23153324 trans-isoeugenol increases expression EXP 6480464 isoeugenol results in increased expression of ZFP36 protein CTD PMID:21969073 trans-isoeugenol multiple interactions EXP 6480464 KT 5720 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein], SB 203580 inhibits the reaction [isoeugenol results in increased expression of ZFP36 protein] CTD PMID:21969073 tributylstannane increases expression ISO RGD:620722 6480464 tributyltin results in increased expression of ZFP36 mRNA CTD PMID:21683754 Tributyltin oxide increases expression ISO RGD:620722 6480464 bistri-n-butyltinoxide results in increased expression of ZFP36 mRNA CTD PMID:17553608 trichloroethene decreases expression ISO RGD:737183 6480464 Trichloroethylene results in decreased expression of ZFP36 mRNA CTD PMID:19448997 trichostatin A multiple interactions ISO RGD:737183 6480464 trichostatin A inhibits the reaction [RU24858 inhibits the reaction [Lipopolysaccharides results in increased expression of ZFP36 mRNA]] CTD PMID:15710351 troglitazone multiple interactions EXP 6480464 [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA, troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZFP36 mRNA] CTD PMID:20847119 tungsten decreases expression ISO RGD:737183 6480464 Tungsten results in decreased expression of ZFP36 mRNA CTD PMID:30912803 undecane increases expression ISO RGD:620722 6480464 undecane results in increased expression of ZFP36 protein CTD PMID:17337753 urethane increases expression EXP 6480464 Urethane results in increased expression of ZFP36 mRNA CTD PMID:28818685 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of ZFP36 mRNA CTD PMID:29154799 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ZFP36 mRNA CTD PMID:25979313 vinclozolin affects expression ISO RGD:620722 6480464 vinclozolin affects the expression of ZFP36 mRNA CTD PMID:19015723 , PMID:23034163 vitamin E decreases expression EXP 6480464 Vitamin E results in decreased expression of ZFP36 mRNA CTD PMID:19244175 zinc atom multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ZFP36 mRNA CTD PMID:18593933 zinc atom increases stability ISO RGD:737183 6480464 Zinc results in increased stability of ZFP36 mRNA CTD PMID:7860645 zinc atom increases expression ISO RGD:737183 6480464 Zinc results in increased expression of ZFP36 mRNA CTD PMID:7860645 zinc atom increases expression ISO RGD:620722 6480464 Zinc deficiency results in increased expression of ZFP36 mRNA CTD PMID:19111725 zinc oxide increases expression EXP 6480464 Zinc Oxide results in increased expression of ZFP36 protein CTD PMID:21769377 zinc protoporphyrin multiple interactions ISO RGD:737183 6480464 zinc protoporphyrin inhibits the reaction [[Nicotine co-treated with Lipopolysaccharides] results in increased expression of ZFP36 mRNA] more ... CTD PMID:24095726 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of ZFP36 mRNA CTD PMID:12756304 zinc(0) multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ZFP36 mRNA CTD PMID:18593933 zinc(0) increases expression ISO RGD:620722 6480464 Zinc deficiency results in increased expression of ZFP36 mRNA CTD PMID:19111725 zinc(0) increases expression ISO RGD:737183 6480464 Zinc results in increased expression of ZFP36 mRNA CTD PMID:7860645 zinc(0) increases stability ISO RGD:737183 6480464 Zinc results in increased stability of ZFP36 mRNA CTD PMID:7860645
